RLS clinical trial - ChloraSolv01 – is completed and the result is to be analyzed
RLS Global is pleased to announce that the database for ChloraSolv01 is closed and RLS has received the first statistical report and results. ChloraSolv01 is a pilot study in which the patient with chronic ulcers on the lower leg or foot is treated with ChloraSolv for five weeks. The study endpoints include for example the reduction of devitalized tissue (necrotic tissue) and reduction of wound size.One important reason for the implementation of the study is to obtain clinical data, to regulatory broaden the indication of use for ChloraSolv, from diabetic foot ulcers to other types of